Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
October 22 2019 - 9:00AM
Artelo Biosciences, Inc. (NASDAQ: ARTL), a
clinical stage biopharmaceutical company developing therapeutics
that modulate the endocannabinoid system, today announced that it
will be presenting at the Dawson James Securities 5th Annual
Small Cap Growth Conference being held on October 28-29, 2019 at
the Wyndham Grand Hotel in Jupiter, Florida.
Gregory D. Gorgas, President and Chief Executive
Officer of Artelo Biosciences, is scheduled to present on Tuesday,
October 29th at 11:20 a.m. Eastern Time, in Track 2 - Preserve
Ballroom B, with one-on-one meetings to be held throughout the
conference.
About Dawson James
SecuritiesDawson James Securities, Inc., a member of
FINRA/SIPC, is a full-service investment bank headquartered in Boca
Raton, FL. http://www.dawsonjames.com.
About Artelo BiosciencesArtelo
Biosciences, Inc. is a San Diego-based biopharmaceutical company
dedicated to the development and commercialization of proprietary
therapeutics targeting the endocannabinoid system. Artelo is
rapidly advancing a portfolio of broadly applicable product
candidates designed to address significant unmet needs in multiple
diseases and conditions, including anorexia, cancer, pain, and
inflammation. Led by proven biopharmaceutical executives
collaborating with highly respected researchers and technology
experts, the Company applies leading edge scientific, regulatory,
and commercial discipline to develop high-impact therapies. More
information is available at www.artelobio.com and Twitter:
@ArteloBio.
Investor Relations
Contact:Crescendo Communications, LLCTel:
212-671-1020Email: ARTL@crescendo-ir.com
Artelo Biosciences (NASDAQ:ARTLW)
Historical Stock Chart
From Jul 2024 to Aug 2024
Artelo Biosciences (NASDAQ:ARTLW)
Historical Stock Chart
From Aug 2023 to Aug 2024